Healthy people
Conditions
Interventions
Subjects take the two assigned dietary fiber foods as test drugs, 3 g each time, twice a day, for 6 consecutive weeks, with a washout period of 4 weeks in between.
Sponsors
Kodama Yuzo
Osawa Ro
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) Persons aged between 20 and 70 at the time of obtaining consent (2) Regardless of gender (3) Patients who gave their voluntary written consent to participate in this clinical research (4) Subjects who can or are expected to be able to continue their usual dietary habits and intake of supplements during the study period
Exclusion criteria
Exclusion criteria: (1) Subjects with a history of diabetes, liver disease, kidney disease, heart disease, lung disease, or other serious diseases (2) Subjects who are currently undergoing treatment (3) Subjects with food and drug allergies (4) Others who are deemed inappropriate by the person in charge of this clinical study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Changes in short-chain fatty acids in feces before and after starting test drug (comparison of changes in short-chain fatty acids before and after administration in one individual) | — |
Secondary
| Measure | Time frame |
|---|---|
| Exploratory endpoint 1. Changes in responsiveness to various dietary fibers by MyDFFS before and after starting the test drug. 2. Changes in the composition of the intestinal flora before and after starting the study drug. | — |
Contacts
Public ContactJun Inoue
Kobe University Hospital
Outcome results
None listed